L.A.M. Pop

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

J.H.A.M. Kaanders, Karien I.E.M. Wijffels, Henri A. M. Marres et al. · PubMed · 2002 · 357 citations

Medicine, Oncology, Pharmacology +14

ARCON: experience in 215 patients with advanced head-and-neck cancer

J.H.A.M. Kaanders, L.A.M. Pop, Henri A. M. Marres et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 184 citations

Medicine, Oncology, Surgery +9

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

J.H.A.M. Kaanders, L.A.M. Pop, Henri A. M. Marres et al. · Radiotherapy and Oncology · 1998 · 110 citations

Medicine, Oncology, Radiation Oncology +12

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

Nanda Horeweg, Remi A. Nout, Ina M. Jürgenliemk‐Schulz et al. · Journal of Clinical Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Long-Term Outcome and Morbidity After Treatment With Accelerated Radiotherapy and Weekly Cisplatin for Locally Advanced Head-and-Neck Cancer: Results of a Multidisciplinary Late Morbidity Clinic

Heidi Rütten, L.A.M. Pop, Geert O. Janssens et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 71 citations

Medicine, Oncology, Radiation Oncology +6